Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyalynx-Ash is a strategic partnership between Hyalynx, Inc. and Ash Ingredients, Inc. focused on the innovation and marketing of hyaluronic acid-based products. The company is notable for being the first in the United States to exclusively market calcium hyaluronate, a specialized form of hyaluronic acid used in dietary supplements, cosmetics, and over-the-counter (OTC) pharmaceuticals. Based in Madisonville, Kentucky, Hyalynx-Ash leverages global sourcing, manufacturing, and scientific validation to provide high-quality ingredients for joint health and personal care. Their business model involves developing novel product ingredients that address unmet needs in the cosmetic and healthcare industries. The partnership utilizes a network of domestic warehouses and facilities across New Jersey, North Carolina, California, and Kentucky to support its global operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyalynx-Ash.